National trends in out-of-pocket prescription drug spending among elderly medicare beneficiaries

References

• Thomas CP, Ritter G, Wallack SS. Growth in prescription drug spending among insured elders. Health Aff. (Millwood) 20(5), 265–277 (2001).
   PubMed Web of Science ®Google Scholar
• Morgan SG. Quantifying components of drug expenditure inflation: the British Columbia seniors’ drug benefit plan. Health Serv. Res. 37(5), 1243–1266 (2002).
   PubMed Web of Science ®Google Scholar
• Martin BC, Miller LS, Kotzan JA. Antipsychotic prescription use and costs for persons with schizophrenia in the 1990s: current trends and five year time series forecasts. Schizophr. Res. 47(2–3), 281–292 (2001).
   PubMed Web of Science ®Google Scholar
• Lund BC, Flaum M, Adam LA, Perry PJ. Psychiatric prescribing trends and practices in Iowa’s prisons. Psychiatr. Serv. 53(8), 1023–1024 (2002).
   PubMed Web of Science ®Google Scholar
• Halbert RJ, Zaher C, Wade S et al. Out-patient cancer drug costs: changes, drivers, and the future. Cancer 94(4), 1142–1150 (2002).
   PubMed Web of Science ®Google Scholar
• Dubois RW, Chawla AJ, Neslusan CA, Smith MW, Wade S. Explaining drug spending trends: does perception match reality? Health Aff. (Millwood) 19(2), 231–239 (2000).
   PubMedGoogle Scholar
• Copeland C. Prescription drugs: issues of cost, coverage, and quality. EBRI Issue Brief 208, 1–21 (1999).
   Google Scholar
• Baugh DK, Pine PL, Blackwell S. Trends in Medicaid prescription drug utilization and payments, 1990–97. Health Care Financ. Rev. 20(3), 79–105 (1999).
   PubMedGoogle Scholar
• Suh DC, Lacy CR, Barone JA, Moylan D, Kostis JB. Factors contributing to trends in prescription drug expenditures. Clin. Ther. 21(7), 1241–1253 (1999).
   PubMed Web of Science ®Google Scholar
• Fink KS, Byrns PJ. Changing prescribing patterns and increasing prescription expenditures in Medicaid. Ann. Fam. Med. 2(5), 488–493 (2004).
   PubMed Web of Science ®Google Scholar
• Kreling D, Mott D, Wiederholt J, Lundy J, Levitt L. In: Prescription Drug Chartbook: An Update. Kaiser Family Foundation, CA, USA (2001).
   Google Scholar
• Anderson GM, Kerluke KJ, Pulcins IR, Hertzman C, Barer ML. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program. Inquiry 30(2), 199–207 (1993).
   PubMed Web of Science ®Google Scholar
• Morgan S. Drug spending in Canada: recent trends and causes. Med. Care 42(7), 635–642 (2004).
   PubMed Web of Science ®Google Scholar
• Mueller C, Schur C, O’Connell J. Prescription drug spending: the impact of age and chronic disease status. Am. J. Public Health 87(10), 1626–1629 (1997).
   PubMed Web of Science ®Google Scholar
• Steinberg EP, Gutierrez B, Momani A et al. Beyond survey data: a claims-based analysis of drug use and spending by the elderly. Health Aff. (Millwood) 19(2), 198–211 (2000).
   PubMed Web of Science ®Google Scholar
• Poisal JA, Murray L. Growing differences between Medicare beneficiaries with and without drug coverage. Health Aff. (Millwood) 20(2), 74–85 (2001).
   PubMed Web of Science ®Google Scholar
• Cunningham PJ. Prescription drug access: not just a Medicare problem. Issue Brief Cent. Stud. Health Syst. Change 51, 1–4 (2002).
   Google Scholar
• Crystal S, Johnson RW, Harman J, Sambamoorthi U, Kumar R. Out-of-pocket healthcare costs among older Americans. J. Gerontol. B. Psychol. Sci. Soc. Sci. 55(1), S51–S62 (2000).
   PubMed Web of Science ®Google Scholar
• Sambamoorthi U, Shea D, Crystal S. Total and out-of-pocket expenditures for prescription drugs among older persons. Gerontologist 43(3), 345–359 (2003).
   PubMed Web of Science ®Google Scholar
• Goldman DP, Zissimopoulos JM. High out-of-pocket healthcare spending by the elderly. Health Aff. (Millwood) 22(3), 194–202 (2003).
   PubMed Web of Science ®Google Scholar
• McKercher PL, Taylor SD, Lee JA, Chao J, Kumar RN. Prescription drug use among elderly and nonelderly families. J. Manag. Care Pharm. 9(1), 19–28 (2003).
   PubMedGoogle Scholar
• Briesacher B, Stuart B, Shea D. Drug coverage for Medicare beneficiaries: why protection may be in jeopardy. Issue Brief (Commonw. Fund) 505, 1–8 (2002).
   PubMedGoogle Scholar
• Federman AD, Adams AS, Ross-Degnan D, Soumerai SB, Ayanian JZ. Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease. JAMA 286(14), 1732–1739 (2001).
   PubMed Web of Science ®Google Scholar
• Rogowski J, Lillard LA, Kington R. The financial burden of prescription drug use among elderly persons. Gerontologist 37(4), 475–482 (1997).
   PubMed Web of Science ®Google Scholar
• Lillard LA, Rogowski J, Kington R. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population. Med. Care 37(9), 926–936 (1999).
   PubMed Web of Science ®Google Scholar
• Atherly A. The effect of Medicare supplemental insurance on Medicare expenditures. Int. J. Health Care Finance Econ. 2(2), 137–162 (2002).
   PubMedGoogle Scholar
• Andrade SE, Gurwitz JH. Drug benefit plans under managed care: to what extent do older subscribers selecting less drug coverage put themselves at increased financial risk? J. Am. Geriatr. Soc. 50(1), 178–181 (2002).
   PubMed Web of Science ®Google Scholar
• Adams AS, Soumerai SB, Ross-Degnan D. The case for a medicare drug coverage benefit: a critical review of the empirical evidence. Annu. Rev. Public Health 22, 49–61 (2001).
   PubMed Web of Science ®Google Scholar
• Poisal JA, Chulis GS. Medicare beneficiaries and drug coverage. Health Aff. (Millwood) 19(2), 248–256 (2000).
   PubMedGoogle Scholar
• Poisal JA. Reporting of drug expenditures in the MCBS. Health Care Financ. Rev. 25(2), 23–36 (2003).
   PubMed Web of Science ®Google Scholar
• Laschober MA, Kitchman M, Neuman P, Strabic AA. Trends in Medicare supplemental insurance and prescription drug coverage, 1996–1999. Health Aff. (Millwood) (Suppl.), W127–W138 (2002).
   Google Scholar
• Gross DJ, Alecxih L, Gibson MJ et al. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries. Health Serv. Res. 34(1 Pt 2), 241–254 (1999).
   PubMed Web of Science ®Google Scholar
• Blendon RJ, Schoen C, DesRoches C, Osborn R, Zapert K. Common concerns amid diverse systems: healthcare experiences in five countries. Health Aff. (Millwood) 22(3), 106–121 (2003).
   PubMed Web of Science ®Google Scholar
• Goldman DP, Smith JP. Methodological biases in estimating the burden of out-of-pocket expenses. Health Serv. Res. 35(6), 1357–1365; discussion 1365–1370 (2001).
   PubMed Web of Science ®Google Scholar
• Alecxih L, Corea J, Gross D et al. Reply: methodological biases in estimating the burden of out-of-pocket expenses. Health Serv. Res. 35(6), 1365–1370 (2001).
   Web of Science ®Google Scholar
• Davis M, Poisal J, Chulis G, Zarabozo C, Cooper B. Prescription drug coverage, utilization, and spending among Medicare beneficiaries. Health Aff. (Millwood) 18(1), 231–243 (1999).
   PubMed Web of Science ®Google Scholar
• Margo L, Rosenbach ML, Lamphere J. Bridging the Gaps Between Medicare and Medicaid: The Case of QMBs and SLMBs. Mathematica Policy Research, Inc. and AARP (1999).
   Google Scholar
• Chu SY, Barker LE, Smith PJ. Racial/ethnic disparities in preschool immunizations: United States, 1996–2001. Am. J. Public Health 94(6), 973–977 (2004).
   PubMed Web of Science ®Google Scholar
• Finlayson SR, Stroupe KT, Joseph GJ, Fisher ES. Using the Veterans Health Administration in-patient care database: trends in the use of antireflux surgery. Eff. Clin. Pract. 5(3 Suppl.), E5 (2002).
   PubMedGoogle Scholar
• Goff DC Jr, Howard G, Wang CH et al. Trends in severity of hospitalized myocardial infarction: the atherosclerosis risk in communities (ARIC) study, 1987–1994. Am. Heart J. 139(5), 874–880 (2000).
   Google Scholar
• Diehr P, Yanez D, Ash A, Hornbrook M, Lin DY. Methods for analyzing healthcare utilization and costs. Ann. Rev. Public Health 20, 125–144 (1999).
   PubMed Web of Science ®Google Scholar
• Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J. Health Econ. 17(3), 283–295 (1998).
   PubMed Web of Science ®Google Scholar
• Halvorsen R, Palmquist R. The Interpretation of dummy variables in semilogarithmic equations. Amer. Econ. Rev. 70(3), 474–475 (1980).
   Web of Science ®Google Scholar
• StataCorp , Stata Statistical Software. Stata Corporation: College Station, TX, USA (2004).
   Google Scholar
• Curtis LH, Law AW, Anstrom KJ, Schulman KA. The insurance effect on prescription drug expenditures among the elderly: findings from the 1997 Medical Expenditure Panel Survey. Med. Care 42(5), 439–446 (2004).
   PubMed Web of Science ®Google Scholar
• Gianfrancesco FD, Baines AP, Richards D. Utilization effects of prescription drug benefits in an aging population. Health Care Financ. Rev. 15(3), 113 (1994).
   PubMedGoogle Scholar
• Goldman DP, Leibowitz AA, Joyce GF et al. Insurance status of HIV-infected adults in the post-HAART era: evidence from the United States. Appl. Health Econ. Health Policy 2(2), 85–90 (2003).
   PubMedGoogle Scholar
• Gross D, Brangan N. Out-of-pocket spending on healthcare by Medicare beneficiaries age 65 and older: 1999 projections. Issue Brief (Public Policy Inst. [Am. Assoc. Retired Pers.]) IB41, 1–14 (1999).
   Google Scholar
• Johnson RW, Sambamoorthi U, Crystal S. Gender differences in pension wealth: estimates using provider data. Gerontologist 39(3), 320–333 (1999).
   PubMed Web of Science ®Google Scholar
• Hurd MD, McGarry K. Medical insurance and the use of healthcare services by the elderly. J. Health Econ. 16(2), 129–154 (1997).
   PubMed Web of Science ®Google Scholar
• Kaiser Family Foundation. How the Medicare HMO Withdrawals Affect Beneficiary Benefits, Costs, and Continuity of Care. The Henry J. Kaiser Foundation, Menlo Park, CA, USA (1999).
   Google Scholar
• Shea DG, Russo PA, Smyer MA. Use of mental health services by persons with a mental illness in nursing facilities: initial impacts of OBRA87. J. Aging Health 12(4), 560–578 (2000).
   PubMed Web of Science ®Google Scholar
• Mulligan K. Access to drugs questionable for medicaid patients under new law. Psychiatr News 39(2), 1a50 (2004).
   Google Scholar
• Stuart B, Ahern F, Rabatin V, Johnson A. Patterns of out-patient prescription drug use among Pennsylvania elderly. Health Care Financ. Rev. 12(3), 61–72 (1991).
   PubMedGoogle Scholar
• Lassila HC, Stoehr GP, Ganguli M et al. Use of prescription medications in an elderly rural population: the MoVIES Project. Ann. Pharmacother. 30(6), 589–595 (1996).
   PubMed Web of Science ®Google Scholar
  BoccutiC, Moon M, Dowling K. Chronic conditions and disabilities: trends and issues for private drug plans. Policy Brief Commonw. Fund 680, 1–10 (2003).
   Google Scholar
• Berk ML, Schur CL, Mohr P. Using survey data to estimate prescription drug costs. Health Aff. (Millwood) 9(3), 146–156 (1990).
   PubMed Web of Science ®Google Scholar
• Moeller JF, Mathiowetz NA. Correcting errors in prescription drug reporting: a critique. Health Aff. (Millwood) 10(1), 210–214 (1991).
   PubMed Web of Science ®Google Scholar
• Eppig FJ Jr, Poisal JA. Medicare beneficiary’s use of prescription drug discount cards, CY 2002. Health Care Financ. Rev. 25(2), 91–94 (2003).
   PubMedGoogle Scholar